User profiles for M. Raiko

Maria Raikou

- Verified email at lse.ac.uk - Cited by 26041

Mikhail Raiko

- Verified email at spbu.ru - Cited by 2029

plasmidSPAdes: assembling plasmids from whole genome sequencing data

D Antipov, N Hartwick, M Shen, M Raiko… - …, 2016 - academic.oup.com
Motivation: Plasmids are stably maintained extra-chromosomal genetic elements that replicate
independently from the host cell’s chromosomes. Although plasmids harbor biomedically …

Metaviral SPAdes: assembly of viruses from metagenomic data

D Antipov, M Raiko, A Lapidus, PA Pevzner - Bioinformatics, 2020 - academic.oup.com
Motivation Although the set of currently known viruses has been steadily expanding, only a
tiny fraction of the Earth’s virome has been sequenced so far. Shotgun metagenomic …

Plasmid detection and assembly in genomic and metagenomic data sets

D Antipov, M Raiko, A Lapidus, PA Pevzner - Genome research, 2019 - genome.cshlp.org
Although plasmids are important for bacterial survival and adaptation, plasmid detection and
assembly from genomic, let alone metagenomic, samples remain challenging. The recently …

[HTML][HTML] Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a …

…, G Carlino, J Taylor, SK Massingham, M Raikou… - The Lancet, 2021 - thelancet.com
Background Ovarian cancer continues to have a poor prognosis with the majority of women
diagnosed with advanced disease. Therefore, we undertook the UK Collaborative Trial of …

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41)

A Gray, M Raikou, A McGuire, P Fenn, R Stevens… - Bmj, 2000 - bmj.com
Objective: To estimate the cost effectiveness of conventional versus intensive blood glucose
control in patients with type 2 diabetes. Design: Incremental cost effectiveness analysis …

Cost-effectiveness of population screening for BRCA mutations in Ashkenazi Jewish women compared with family history–based testing

…, M Burnell, A McGuire, M Raikou… - Journal of the …, 2015 - academic.oup.com
Background: Population-based testing for BRCA1/2 mutations detects the high proportion of
carriers not identified by cancer family history (FH)–based testing. We compared the cost-…

The economics of screening and treatment in type 2 diabetes mellitus

M Raikou, A McGuire - Pharmacoeconomics, 2003 - Springer
A systematic review of the literature was conducted to identify articles on the economics of
type 2 diabetes mellitus. Articles were classified into two main categories: cost/burden-of-…

Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51)

P Clarke, A Gray, A Adler, R Stevens, M Raikou, C Cull… - Diabetologia, 2001 - Springer
Aims/hypothesis. To estimate the economic efficiency of intensive blood-glucose control with
metformin compared with conventional therapy primarily with diet in overweight patients …

Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations

…, R Taylor, C Jacobs, R Legood, M Raikou… - Journal of medical …, 2016 - jmg.bmj.com
Background Newer approaches to genetic counselling are required for population-based
testing. We compare traditional face-to-face genetic counselling with a DVD-assisted approach …

Cost‐effectiveness analysis of oxaliplatin compared with 5‐fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US

S Aballéa, JVM Chancellor, M Raikou… - … Journal of the …, 2007 - Wiley Online Library
… /m 2 on Day 1, leucovorin 200 mg/m 2 on Days 1 and 2, 5-FU bolus 400 mg/m 2 and 5-FU
continuous infusion 600 mg/m 2 … 200 mg/m 2 and Days 1 and 2, 5-FU bolus 400 mg/m 2 and 5-…